Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Beauvais D, Labeyrie C, Cauquil C, Francou B, Eliahou L, Not A, Echaniz-Laguna A, Adam C, Slama MS, Benmalek A, Leonardi L, Rouzet F, Adams D, Algalarrondo V, Beaudonnet G. Beauvais D, et al. Among authors: not a. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):489-499. doi: 10.1136/jnnp-2023-332180. J Neurol Neurosurg Psychiatry. 2024. PMID: 37875336 Free PMC article.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
[Motor and/or sensory deficit of the limbs].
Not A, Beaudonnet G, Denier C. Not A, et al. Rev Prat. 2017 Dec;67(10):e479-e488. Rev Prat. 2017. PMID: 30512623 French. No abstract available.
[Ischemic strokes].
Not A, Beaudonnet G, Denier C. Not A, et al. Rev Prat. 2017 Dec;67(10):e489-e490. Rev Prat. 2017. PMID: 30512624 French. No abstract available.
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.
Plaçais L, Michot JM, Champiat S, Romano-Martin P, Baldini C, Joao MS, Marabelle A, Voisin AL, Not A, Labeyrie C, Beaudonnet G, Laparra A, Maria ATJ, Masseau A, Dehette S, Deleporte A, Echaniz-Laguna A, Denier C, Adams D, Lambotte O, Noel N, Cauquil C. Plaçais L, et al. Among authors: not a. Brain Commun. 2021 Oct 1;3(4):fcab220. doi: 10.1093/braincomms/fcab220. eCollection 2021. Brain Commun. 2021. PMID: 34651126 Free PMC article.
Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P, Not A, Theaudin M, Denier C, Masnou P, Sarov M, Adam C, Cauquil C, Adams D. Lozeron P, et al. Among authors: not a. Muscle Nerve. 2016 May;53(5):683-9. doi: 10.1002/mus.24942. Epub 2016 Jan 19. Muscle Nerve. 2016. PMID: 26467654
Tolerability has yet to be demonstrated in this age group. METHODS: This is a retrospective study of adverse reactions among consecutive patients treated with IVIg for neurological disorders. ...Adverse reactions mainly depend on IVIg preparation and administration. Renal …
Tolerability has yet to be demonstrated in this age group. METHODS: This is a retrospective study of adverse reactions among consecut …
Expression of Yo Antigen in a Prostatic Adenocarcinoma.
Rosine N, Chrétien P, Adam C, Beaudonnet G, Not A, Drai J, Vahedi K, Cauquil C, Theaudin M. Rosine N, et al. Among authors: not a. Can J Neurol Sci. 2017 Mar;44(2):221-223. doi: 10.1017/cjn.2016.400. Can J Neurol Sci. 2017. PMID: 28231864 No abstract available.
LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2.
Peretti A, Perie M, Vincent D, Bouhour F, Dieterich K, Mallaret M, Duval F, Goizet C, Juntas-Morales R, Magy L, Solé G, Nollet S, Not A, Léonard-Louis S, Francou B, Leguern E, Lia AS, Magdelaine C, Latour P, Stojkovic T. Peretti A, et al. Among authors: not a. Eur J Hum Genet. 2019 Sep;27(9):1406-1418. doi: 10.1038/s41431-019-0403-8. Epub 2019 Apr 17. Eur J Hum Genet. 2019. PMID: 30996334 Free PMC article.
26 results